{"id":"placebo-teriparatide","safety":{"commonSideEffects":[]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo teriparatide","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:51:40.145427+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:51:46.895050+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo teriparatide","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:51:47.755891+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Parathyroid hormone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:51:48.378124+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201549/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:51:48.227292+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo, it contains no active pharmaceutical ingredient and serves as a comparator arm in randomized controlled trials of teriparatide (recombinant human parathyroid hormone 1-34). The placebo allows researchers to isolate the true therapeutic effects of teriparatide from natural disease progression and patient expectation effects.","oneSentence":"Placebo teriparatide is an inactive control formulation used in clinical trials to compare against active teriparatide treatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:27.795Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:51:50.157151+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Control arm in clinical trials of teriparatide for osteoporosis"}]},"trialDetails":[{"nctId":"NCT01225055","phase":"PHASE2","title":"Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury","status":"COMPLETED","sponsor":"Thomas J. Schnitzer","startDate":"2010-10","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":60},{"nctId":"NCT03994172","phase":"PHASE4","title":"Novel Combination Therapy for Osteoporosis in Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-07-01","conditions":"Male Osteoporosis","enrollment":40},{"nctId":"NCT03133195","phase":"PHASE3","title":"The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2017-05-17","conditions":"Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed","enrollment":50},{"nctId":"NCT06303284","phase":"PHASE1, PHASE2","title":"Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-01-01","conditions":"Ankle Fractures","enrollment":80},{"nctId":"NCT06061354","phase":"PHASE4","title":"Teriparatide on Maxillary Sinus Floor Osseointegration","status":"UNKNOWN","sponsor":"Universidad de Valparaiso","startDate":"2023-08-23","conditions":"Bone Regeneration","enrollment":42},{"nctId":"NCT01896011","phase":"PHASE3","title":"Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2013-07","conditions":"Non Displaced Atypical Femoral Fractures","enrollment":34},{"nctId":"NCT03072147","phase":"PHASE2","title":"Teriparatide as a Chondroregenerative Therapy in OA","status":"COMPLETED","sponsor":"Christopher Ritchlin","startDate":"2017-05-01","conditions":"Knee Osteoarthritis, Cartilage Degeneration","enrollment":76},{"nctId":"NCT04589819","phase":"PHASE4","title":"Fracture Recovery for Returning to Duty (Teriparatide STRONG)","status":"ENROLLING_BY_INVITATION","sponsor":"University of South Carolina","startDate":"2022-12-08","conditions":"Stress Fracture of Tibia or Fibula","enrollment":183},{"nctId":"NCT00896532","phase":"PHASE2","title":"Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-06-03","conditions":"Low Bone Mineral Density, Postmenopausal Osteoporosis","enrollment":419},{"nctId":"NCT02972424","phase":"PHASE2","title":"PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-05-01","conditions":"Osteoporotic Fractures","enrollment":35},{"nctId":"NCT02023411","phase":"PHASE2","title":"Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2014-01","conditions":"Diabetic Neuropathic Arthropathy","enrollment":20},{"nctId":"NCT04003467","phase":"PHASE2","title":"A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2019-06-30","conditions":"Osteoporosis","enrollment":161},{"nctId":"NCT01679080","phase":"PHASE2","title":"The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2012-11","conditions":"Osteogenesis Imperfecta","enrollment":9},{"nctId":"NCT01292252","phase":"PHASE4","title":"Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion","status":"COMPLETED","sponsor":"Shane Burch","startDate":"2011-08","conditions":"Lumbar Spondylosis, Lumbar Spondylolisthesis, Adult Degenerative Lumbar Scoliosis","enrollment":36},{"nctId":"NCT04473989","phase":"PHASE2","title":"Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-01","conditions":"Colles' Fracture","enrollment":80},{"nctId":"NCT01440803","phase":"PHASE2","title":"Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women","status":"COMPLETED","sponsor":"Elizabeth Shane","startDate":"2012-08-02","conditions":"Adult Idiopathic Generalized Osteoporosis","enrollment":41},{"nctId":"NCT00887354","phase":"PHASE4","title":"A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-04","conditions":"Osteoporosis","enrollment":224},{"nctId":"NCT01709110","phase":"PHASE4","title":"VERtebral Fracture Treatment Comparisons in Osteoporotic Women","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-10","conditions":"Postmenopausal Osteoporosis","enrollment":1366},{"nctId":"NCT00131469","phase":"PHASE4","title":"Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2005-06","conditions":"Osteogenesis Imperfecta","enrollment":79},{"nctId":"NCT00489918","phase":"PHASE2","title":"Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Zosano Pharma Corporation","startDate":"2007-06","conditions":"Osteoporosis","enrollment":165},{"nctId":"NCT01279187","phase":"PHASE2","title":"The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Implant","enrollment":27},{"nctId":"NCT00471237","phase":"PHASE2","title":"A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2007-05-14","conditions":"Osteoporosis","enrollment":564},{"nctId":"NCT00542425","phase":"PHASE2","title":"Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2007-04","conditions":"Osteoporosis","enrollment":222},{"nctId":"NCT00759772","phase":"PHASE2","title":"The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-09","conditions":"Anorexia Nervosa, Osteoporosis","enrollment":23},{"nctId":"NCT01343004","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2011-04","conditions":"Osteoporosis, Postmenopausal Osteoporosis","enrollment":2463},{"nctId":"NCT01935479","phase":"PHASE1","title":"A Phase I Study of AK159 in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Asahi Kasei Pharma Corporation","startDate":"2013-08","conditions":"Osteoporosis","enrollment":170},{"nctId":"NCT01309399","phase":"NA","title":"Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur","status":"COMPLETED","sponsor":"Health Research, Inc.","startDate":"2010-08","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT01551602","phase":"PHASE1","title":"Clinical Study of AK159 in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Asahi Kasei Pharma Corporation","startDate":"2012-03","conditions":"Osteoporosis","enrollment":132},{"nctId":"NCT02202603","phase":"PHASE1","title":"A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2011-07","conditions":"Drug Safety","enrollment":42},{"nctId":"NCT01734824","phase":"PHASE4","title":"Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo","status":"SUSPENDED","sponsor":"Medical University of Vienna","startDate":"2012-05","conditions":"Bone Marrow Oedema Syndrome, High Turnover Bone Disease, Quality of Life","enrollment":90},{"nctId":"NCT02091492","phase":"PHASE3","title":"Teriparatide for Fracture Repair in Humans","status":"WITHDRAWN","sponsor":"Medical University of Vienna","startDate":"2014-06","conditions":"Osteoporosis, Age-Related, Humeral Fractures","enrollment":""},{"nctId":"NCT00221299","phase":"PHASE4","title":"Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2005-09","conditions":"Osteoporosis","enrollment":60},{"nctId":"NCT01473602","phase":"PHASE3","title":"Second Study of the Effect of Teriparatide on Hip Fracture Healing","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-01","conditions":"Femur Neck Fracture","enrollment":39},{"nctId":"NCT01473589","phase":"PHASE3","title":"Effect of Teriparatide on Hip Fracture Healing","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-02","conditions":"Femur Neck Fracture","enrollment":122},{"nctId":"NCT02416271","phase":"PHASE4","title":"The Forteo Alendronate Comparator Trial","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2001-04","conditions":"Osteoporosis","enrollment":203},{"nctId":"NCT00594906","phase":"NA","title":"Use of Teriparatide to Accelerate Fracture Healing","status":"TERMINATED","sponsor":"University of Rochester","startDate":"2008-01","conditions":"Pelvic Fracture","enrollment":10},{"nctId":"NCT01611571","phase":"PHASE3","title":"Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis","status":"COMPLETED","sponsor":"Columbia University","startDate":"2003-12","conditions":"Osteoporosis","enrollment":31},{"nctId":"NCT01063504","phase":"PHASE2","title":"Teriparatide for Improved Knee Prosthesis Fixation","status":"COMPLETED","sponsor":"University Hospital, Linkoeping","startDate":"2010-02","conditions":"Osteoarthritis of the Knee","enrollment":60},{"nctId":"NCT00927186","phase":"PHASE4","title":"Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-07","conditions":"Osteoporosis, Post-menopausal","enrollment":69},{"nctId":"NCT01321723","phase":"PHASE2","title":"Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women","status":"COMPLETED","sponsor":"Unigene Laboratories Inc.","startDate":"2011-02","conditions":"Postmenopausal Osteoporosis","enrollment":97},{"nctId":"NCT00891553","phase":"","title":"CR9112792, a Follow-up of Study CR9108963","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-03","conditions":"Osteoporosis","enrollment":171},{"nctId":"NCT00065637","phase":"PHASE3","title":"Once Weekly Parathyroid Hormone for Osteoporosis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2003-12","conditions":"Osteopenia, Osteoporosis","enrollment":50},{"nctId":"NCT01250145","phase":"PHASE1","title":"A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-11","conditions":"Osteoporosis, Postmenopausal","enrollment":251},{"nctId":"NCT01173081","phase":"PHASE4","title":"The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures","status":"UNKNOWN","sponsor":"Ohio Orthopedic Center of Excellence","startDate":"2010-07","conditions":"Fractures","enrollment":38},{"nctId":"NCT01604057","phase":"PHASE2","title":"Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass","status":"UNKNOWN","sponsor":"Azelon Pharmaceuticals","startDate":"2011-11","conditions":"Osteoporosis, Osteopenia","enrollment":130},{"nctId":"NCT00343252","phase":"PHASE3","title":"Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-06","conditions":"Osteoporosis, Postmenopausal, Back Pain, Spinal Fracture","enrollment":712},{"nctId":"NCT01224717","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-09","conditions":"Post-menopausal Osteoporosis","enrollment":104},{"nctId":"NCT00439244","phase":"PHASE3","title":"Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-12","conditions":"Osteoporosis","enrollment":412},{"nctId":"NCT00433160","phase":"PHASE3","title":"Phase 3 Clinical Trial of Teriparatide in Japan","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2007-01","conditions":"Osteoporosis","enrollment":207},{"nctId":"NCT00277706","phase":"PHASE1","title":"Impact of Parathyroid Hormone (PTH) on Osseous Cavity","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2004-08","conditions":"Bone Loss, Periodontitis","enrollment":40},{"nctId":"NCT00051558","phase":"PHASE3","title":"Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2002-11","conditions":"Osteoporosis","enrollment":428},{"nctId":"NCT00670501","phase":"PHASE3","title":"Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"1996-08","conditions":"Osteoporosis, Postmenopausal","enrollment":1637},{"nctId":"NCT00190944","phase":"PHASE2","title":"Effects of Teriparatide on Distal Radius Fracture Healing","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2004-12","conditions":"Colles' Fracture","enrollment":105},{"nctId":"NCT00035256","phase":"PHASE4","title":"Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2001-10","conditions":"Osteoporosis, Postmenopausal","enrollment":330},{"nctId":"NCT00046137","phase":"PHASE3","title":"Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"","conditions":"Osteoporosis, Postmenopausal","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1201549"},"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Teriparatide","PTH1-34","Forteo","PTH 1-34"],"phase":"marketed","status":"active","brandName":"Placebo teriparatide","genericName":"Placebo teriparatide","companyName":"University of California, San Francisco","companyId":"university-of-california-san-francisco","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo teriparatide is an inactive control formulation used in clinical trials to compare against active teriparatide treatment. Used for Control arm in clinical trials of teriparatide for osteoporosis.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:51:50.157151+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}